跳至主要内容
临床试验/CTRI/2025/01/079771
CTRI/2025/01/079771已完成2/3 期

Role of homoeopathic constitutional medicines in cases of obsessive compulsive disorder (dsm -5 ) assessed by yale brown obsessive compulsive scale

DR MAUNIL D PATEL1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
YALE BROWN OBSESSIVE COMPULSIVE SCALE TO ASSESS THE REDUCTION OF SEVERITY OF SYMPTOMS OF OCD

研究概览

简要总结

THIS STUDY IS A PROSPECTIVE STUDY PRE TEST POST TEST ONE GROUP EXPERIMENTAL STUDY TO ASSESS THE ROLE OF HOMOEOPATHIC CONSTITUTIONAL MEDICINE FOR 12 MONTH IN 30 PARTICIPANTS WITH OBSESSIVE COMPULSIVE DISORDER THAT WILL BE CONDUCTED AS PER INCLUSION AND EXCLUSION CRITERIA FROM OUTPATIENT DEPARTMENT AND THE PRIMARY OUTCOME MEASURE WILL ASSESS THE REDUCTION OF SEVERITY OF SYMPTOMS OF THE PARTICIPANTS USING YALE BROWN OBSESSIVE COMPULSIVE SCALE AND SECONDARY OUT COME WILL BE ASSESED WITH SHEEHAN DISABILITY SCALE  BOTH SCORE WILL BE ASSESED AT BASELINE 6 MONTH AND AT THE END OF TREATMENT 12 MONTH  FOLLOW UP AS PER NEED OF CASE FOR 12 MONTH OF DURATION

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)

入选标准

  • Gender Men and women and transgender Diagnosis Diagnosed through sign and symptoms describe in DSM 5 diagnostic and statistical manual of mental disorder 5 Score Cases ranging the score between 10 to 30 according to Ybocs scale.

排除标准

  • Patient having certain co morbidities such as depression with suicidal tendencies uncontrolled diabetes renal disease like CKD cardiac anomalies like cardiomegaly uncontrolled hpertension neurological problems like complete paralysis coma etc Patient having suicidal tendencies with OCD Patient if taking any conventional mode of treatments such as anxiolytic antidepressant Pregnant women.

结局指标

主要结局

YALE BROWN OBSESSIVE COMPULSIVE SCALE TO ASSESS THE REDUCTION OF SEVERITY OF SYMPTOMS OF OCD

时间窗: SCORE WILL BE ASSESED AT BASELINE 6 MONTHS AND AT THE END OF TREATMENT 12 MONTH

次要结局

  • SHEEHAN DISABILITY SCALE TO ASSESS IMPROVEMENT IN QUALITY OF LIFE(SCORE WILL BE ASSESSED AT BASELINE 6 MONTH AND AT THE END OF TREATMENT 12 MONTH)

研究者

发起方
DR MAUNIL D PATEL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR MAUNIL DILIPKUMAR PATEL

SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE

研究点 (1)

Loading locations...

相似试验